Stocks and Investing
Stocks and Investing
Fri, April 21, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Jasper Hellweg Maintained (UTHR) at Strong Buy with Decreased Target to $280 on, Apr 21st, 2023
Jasper Hellweg of Argus Research, Maintained "United Therapeutics Corporation" (UTHR) at Strong Buy with Decreased Target from $300 to $280 on, Apr 21st, 2023.
Jasper has made no other calls on UTHR in the last 4 months.
There are 4 other peers that have a rating on UTHR. Out of the 4 peers that are also analyzing UTHR, 0 agree with Jasper's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Jasper
- Ashwani Verma of "UBS" Maintained at Strong Buy with Decreased Target to $310 on, Monday, April 10th, 2023
- Terence Flynn of "Morgan Stanley" Maintained at Buy with Decreased Target to $316 on, Monday, April 10th, 2023
- Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $300 on, Thursday, February 23rd, 2023
- Jessica Fung of "JP Morgan" Maintained at Buy with Increased Target to $280 on, Thursday, February 23rd, 2023
Contributing Sources